PharmaCyte Biotech Discusses Patient Enrollment and TD2’s Role in Upcoming Clinical Trial Biotech Investing
NewLink Genetics to Host Its Fourth Quarter and Year End 2016 Financial Results Conference Call on February 28, 2017 Biotech Investing
Heat Biologics Presents Immune Data on its HS-410 Phase 2 Bladder Cancer Trial at the Genitourinary Cancers Symposium Biotech Investing
Abeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at the 13th Annual WORLDSymposium™ 2017 Biotech Investing
Revive Therapeutics Announces Expansion into Cannabinoid-Based Therapies Targeting Liver Diseases Biotech Investing
CTD Holdings Presents Compassionate Use Data on Trappsol(R) Cyclo(TM) to Treat Niemann-Pick Disease Type C and Provides Update on Progress of U.S. and EU Clinical Trials at 13th Annual WORLDSymposium Biotech Investing
Alder BioPharmaceuticals to Host Conference Call to Discuss Fourth Quarter and Full Year 2016 Financial and Operating Results Biotech Investing
